Athletic apparel company Under Armour (NYSE:UAA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 11.4% year on year to $1.18 billion. On the other hand, next quarter’s revenue guidance of $1.13 billion was less impressive, coming in 3.4% below analysts’ estimates. Its non-GAAP loss of $0.08 per share was in line with analysts’ consensus estimates.
Bernstein bullish on Coinbase after S&P 500 inclusion, projecting $16B in potential inflows from passive & active investment. Also first crypto firm to join benchmark index.
E-commerce and gaming company Sea (NYSE:SE) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 29.6% year on year to $4.84 billion. Its GAAP profit of $0.65 per share was 7.1% above analysts’ consensus estimates.
USD/CHF has a pronounced seasonal tendency for weakness through late spring and summer, a pattern that could come into sharper focus as the pair approaches key resistance.
China firmly rejected responsibility for the U.S. fentanyl crisis on Tuesday, calling Washington's punitive tariffs "unreasonable" even as broader trade tensions between the world's two largest economies show signs of easing.
Pharma stocks saw a relief rally, with Sun Pharma and Dr. Reddy’s gaining over 1% each, after U.S. President Donald Trump’s executive order on drug pricing was considered less stringent than anticipated.
WTI crude oil prices rose to $63 per barrel on Monday, hitting a two-week high, after the US and China agreed to cut most tariffs on each other’s goods.
On Monday, speaking on Kitco News, Stephanie Pomboy, the founder of macro research firm MacroMavens, rained on Wall Street's victory parade following the trade war de-escalation between the U.S. and China.
Dogecoin (CRYPTO: DOGE) correction continued into Tuesday morning, although one analyst seemed confident the coin would reach $0.27 on the next leg up.
